BR112014030243B1 - Métodos para diagnosticar doença valvular crônica - Google Patents
Métodos para diagnosticar doença valvular crônica Download PDFInfo
- Publication number
- BR112014030243B1 BR112014030243B1 BR112014030243-0A BR112014030243A BR112014030243B1 BR 112014030243 B1 BR112014030243 B1 BR 112014030243B1 BR 112014030243 A BR112014030243 A BR 112014030243A BR 112014030243 B1 BR112014030243 B1 BR 112014030243B1
- Authority
- BR
- Brazil
- Prior art keywords
- sample
- amount
- animal
- metabolites
- valvular disease
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G01N33/5758—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/491—Blood by separating the blood components
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6806—Determination of free amino acids
- G01N33/6812—Assays for specific amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/326—Arrhythmias, e.g. ventricular fibrillation, tachycardia, atrioventricular block, torsade de pointes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/16—Phosphorus containing
- Y10T436/163333—Organic [e.g., chemical warfare agents, insecticides, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/20—Oxygen containing
- Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
- Y10T436/201666—Carboxylic acid
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Ecology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261655704P | 2012-06-05 | 2012-06-05 | |
| US61/655,704 | 2012-06-05 | ||
| PCT/US2013/044008 WO2013184628A1 (en) | 2012-06-05 | 2013-06-04 | Methods for diagnosing chronic valvular disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014030243A2 BR112014030243A2 (pt) | 2017-06-27 |
| BR112014030243B1 true BR112014030243B1 (pt) | 2022-07-05 |
Family
ID=48626663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014030243-0A BR112014030243B1 (pt) | 2012-06-05 | 2013-06-04 | Métodos para diagnosticar doença valvular crônica |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20150153353A1 (enExample) |
| EP (1) | EP2856170B1 (enExample) |
| JP (1) | JP6174689B2 (enExample) |
| CN (1) | CN104364658B (enExample) |
| AU (1) | AU2013271879B2 (enExample) |
| BR (1) | BR112014030243B1 (enExample) |
| CA (1) | CA2875331C (enExample) |
| ES (1) | ES2687979T3 (enExample) |
| IN (1) | IN2014DN10127A (enExample) |
| MX (1) | MX358561B (enExample) |
| RU (1) | RU2667634C2 (enExample) |
| WO (1) | WO2013184628A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10184932B2 (en) * | 2015-12-07 | 2019-01-22 | Zora Biosciences Oy | Use of ceramides and LPLs in diagnosing CVD |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060257943A1 (en) * | 2005-01-25 | 2006-11-16 | Cis Biotech, Inc. | Ischemic biomarkers and their use to predict adverse neurological events from surgery |
| EP2164977B1 (en) * | 2007-07-17 | 2013-10-30 | Metabolon, Inc. | Biomarkers for pre-diabetes and methods using the same |
| CA2705325C (en) * | 2007-11-09 | 2016-11-01 | The Board Of Regents Of The University Of Texas System | Micro-rnas of the mir-15 family modulate cardiomyocyte survival and cardiac repair |
| EP2283358B1 (en) * | 2008-04-29 | 2015-04-22 | Immunexcite, Inc. | Immunomodulating compositions and methods of use thereof |
| PL2271933T3 (pl) * | 2008-05-07 | 2013-05-31 | Univ Strathclyde | System i sposób charakteryzowania komórek |
| RU2011135768A (ru) * | 2009-01-29 | 2013-03-10 | Эбботт Лэборетриз | Белки, связывающие il-1 |
| MX2013000917A (es) * | 2010-07-23 | 2013-07-05 | Harvard College | Metodos para detectar las enfermedades o condiciones usando celulas fagociticas. |
-
2013
- 2013-06-04 IN IN10127DEN2014 patent/IN2014DN10127A/en unknown
- 2013-06-04 JP JP2015516104A patent/JP6174689B2/ja active Active
- 2013-06-04 ES ES13729199.3T patent/ES2687979T3/es active Active
- 2013-06-04 US US14/405,325 patent/US20150153353A1/en not_active Abandoned
- 2013-06-04 MX MX2014014791A patent/MX358561B/es active IP Right Grant
- 2013-06-04 RU RU2014153109A patent/RU2667634C2/ru active
- 2013-06-04 WO PCT/US2013/044008 patent/WO2013184628A1/en not_active Ceased
- 2013-06-04 CN CN201380029514.3A patent/CN104364658B/zh active Active
- 2013-06-04 BR BR112014030243-0A patent/BR112014030243B1/pt active IP Right Grant
- 2013-06-04 EP EP13729199.3A patent/EP2856170B1/en active Active
- 2013-06-04 CA CA2875331A patent/CA2875331C/en active Active
- 2013-06-04 AU AU2013271879A patent/AU2013271879B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2687979T3 (es) | 2018-10-30 |
| RU2014153109A (ru) | 2016-08-10 |
| JP6174689B2 (ja) | 2017-08-02 |
| MX2014014791A (es) | 2015-02-24 |
| CN104364658B (zh) | 2017-06-30 |
| AU2013271879B2 (en) | 2019-03-28 |
| RU2667634C2 (ru) | 2018-09-21 |
| CA2875331A1 (en) | 2013-12-12 |
| WO2013184628A1 (en) | 2013-12-12 |
| AU2013271879A1 (en) | 2014-12-18 |
| IN2014DN10127A (enExample) | 2015-08-21 |
| CA2875331C (en) | 2022-11-29 |
| US20150153353A1 (en) | 2015-06-04 |
| EP2856170B1 (en) | 2018-07-25 |
| BR112014030243A2 (pt) | 2017-06-27 |
| MX358561B (es) | 2018-08-24 |
| JP2015524066A (ja) | 2015-08-20 |
| CN104364658A (zh) | 2015-02-18 |
| EP2856170A1 (en) | 2015-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014265669B2 (en) | Biomarkers related to kidney function and methods using the same | |
| Maniscalco et al. | Clinical metabolomics of exhaled breath condensate in chronic respiratory diseases | |
| Snowden et al. | Application of metabolomics approaches to the study of respiratory diseases | |
| US10006925B2 (en) | Methods and systems for metabolite and/or lipid-based detection of colorectal cancer and/or adenomatous polyps | |
| JP7288283B2 (ja) | 小児がん検査用尿中代謝物マーカー | |
| Bu et al. | Metabolomics: a revolution for novel cancer marker identification | |
| Hanna et al. | Urinary metabolomic markers of aminoglycoside nephrotoxicity in newborn rats | |
| Hanna et al. | Metabolomics in pediatric nephrology: emerging concepts | |
| Djukovic et al. | Colorectal cancer detection using targeted LC-MS metabolic profiling | |
| Borras et al. | Exhaled breath condensate methods adapted from human studies using longitudinal metabolomics for predicting early health alterations in dolphins | |
| Azagra et al. | Ammonium quantification in human plasma by proton nuclear magnetic resonance for staging of liver fibrosis in alcohol‐related liver disease and nonalcoholic fatty liver disease | |
| US20240352542A1 (en) | Means and methods for diagnosing a viral infection or a disease associated therewith | |
| BR112014030243B1 (pt) | Métodos para diagnosticar doença valvular crônica | |
| JP7226732B2 (ja) | 尿中腫瘍マーカーによるがん検出方法、キット及び装置 | |
| Carling et al. | UK Metabolic Biochemistry Network Recommendations for the Analysis of Urinary Organic Acids by Gas Chromatography Mass Spectrometry | |
| Banoei | Metabolomics Study of the Diagnosis and Prognosis of Severe Traumatic Brain Injury (sTBI) | |
| Xu | Liquid chromatography-mass spectrometry based metabolomics, lipidomics and epitranscriptomics. | |
| WANG et al. | Evaluation of chemiluminescence immunoassay for detecting blood levels of aldosterone and renin with its diagnostic value of primary aldosteronism | |
| HK1222905B (en) | Biomarkers related to kidney function and methods using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
| B25A | Requested transfer of rights approved |
Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH) |
|
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/06/2013, OBSERVADAS AS CONDICOES LEGAIS |